secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0001493152-21-026622
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience reports FY2021 net loss of $2.3M; product sales drop 47% YoY
----------------------------------------------------------------------------

- Net product sales $3.698M, down 47% from $6.917M in FY2020.
- Net loss of $2.3M vs net income of $4K in prior year; diluted loss per share $(0.03).
- Gross margin fell to 50% from 58% due to product mix shift.
- Cash used in operations $1.2M vs cash provided $669K in prior year.
- Business updates: ongoing work with Taylor Farms, new adoption by citrus packer and indoor farming firm, new sales hire.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315221026622/0001493152-21-026622-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315221026622/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-026622

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer